直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Offices
  • Careers
Finnegan
Clinton P. Greub
Associate
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4020
clinton.greub@finnegan.com clinton.greub@finnegan.com

Clinton P. Greub

Associate

  • +1 202 408 4020 +1 202 408 4020
  • clinton.greub@finnegan.com clinton.greub@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Clinton Greub has a mixed practice of patent litigation and patent prosecution. With a background in cellular and molecular biology, his focus is primarily in the biotechnological and pharmaceutical areas. 

Clinton's graduate research focused on gene stacking techniques, using recombinases for gene integration and nucleases for marker gene deletion. His thesis concentrated on correlating gene expression analysis with phenotypic structures to develop drought resistant rice.

While pursuing his law degree, Clinton participated in the Patent Experience Extern Program (PEEP) at the U.S. Patent and Trademark Office (USPTO), and he worked as a summer associate at Finnegan. Prior to law school, Clinton worked at the U.S. Department of Agriculture and at DuPont Pioneer, Inc.

Before beginning his legal career, Clinton served four years on active duty in the U.S. Army. He was stationed in Fort Bliss, Texas, and in South Korea, where he was a tactical controller for Patriot missile systems.

Clinton maintains an active pro bono practice. He has successfully represented clients in various matters, including landlord/tenant disputes and veterans appeals

Et Cetera

  • Student attorney, Health Justice Alliance, 2019. 
  • Thesis: “A Morpho-Physiological Analysis of Diverse Drought Resistant and Sensitive Rice Genotypes to Identify Distinguishing Anatomical Root Phenes,” 2015.  

Experience

Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million

Assessed IP issues as part of due diligence efforts in $45 million acquisition deal focused on DNA writing via CRISPR.

Insights

At the PTAB Blog

Federal Circuit: Mandamus Petitions Challenging Institution Denial Are Unlikely to Show Right to Relief Federal Circuit: Mandamus Petitions Challenging Institution Denial Are Unlikely to Show Right to Relief

March 31, 2021

At the PTAB Blog

Federal Circuit Partially Vacates PTAB Decision in Mixed Victory for Samsung Federal Circuit Partially Vacates PTAB Decision in Mixed Victory for Samsung

February 22, 2021

Federal Circuit IP Blog

Opting for Continued Examination May Lead to a Shorter Patent Term Adjustment Opting for Continued Examination May Lead to a Shorter Patent Term Adjustment

February 16, 2021

Prosecution First Blog

When Will They Ever Learn? Subject Matter Disclosed in the Patent Specification But Never Claimed is Dedicated to the Public When Will They Ever Learn? Subject Matter Disclosed in the Patent Specification But Never Claimed is Dedicated to the Public

May 24, 2019

News

Press Release

46 Finnegan Attorneys Named to 2021 Capital Pro Bono Honor Roll 46 Finnegan Attorneys Named to 2021 Capital Pro Bono Honor Roll

June 3, 2022

Admissions and Education

Admissions

  • District of Columbia
  • Missouri

Education

Georgetown University Law Center
J.D., 2020
University of Arkansas
M.S., Cellular and Molecular Biology, 2015
University of Arkansas
B.A., Biology, 2012

Clinton's Practices

Patent Litigation
Patent Office Examinations
Prosecution

Clinton's Industries

Blockchain, NFTs, and Other Digital Assets
Life Sciences
Biologics
Biotechnology
Pharmaceutical

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

  • Privacy
  • Disclaimer
  • EEO Statement

© 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP